Evidence map›Paper›PMID 36429423›Full record

ArticleInternational journal of environmental research and public health2022

Development and Evaluation of a Digital Health Intervention to Prevent Type 2 Diabetes in Primary Care: The PREDIABETEXT Study Protocol for a Randomised Clinical Trial.

Aina M Galmes-Panades, Escarlata Angullo, Sofía Mira-Martínez, Miquel Bennasar-Veny, Rocío Zamanillo-Campos, Rocío Gómez-Juanes, Jadwiga Konieczna, Rafael Jiménez, Maria Jesús Serrano-Ripoll, Maria Antonia Fiol-deRoque and 16 more

Abstract readClinical Trial Protocol
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Aina M Galmes-PanadesGlobal Health and Lifestyle (EVES Group), Health Research Institute of the Balearic Islands (IdISBa), University Hospital Son Espases (HUSE), 07120 Palma, Spain.ORCID 0000-0001-6977-9874
Escarlata AngulloEscola Graduada Primary Health Care Center, Balearic Health Service, 07002 Palma de Mallorca, Spain.
Sofía Mira-MartínezHealth Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain.ORCID 0000-0002-6402-4760
Miquel Bennasar-VenyGlobal Health and Lifestyle (EVES Group), Health Research Institute of the Balearic Islands (IdISBa), University Hospital Son Espases (HUSE), 07120 Palma, Spain.ORCID 0000-0003-1668-2141
Rocío Zamanillo-CamposHealth Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain.
Rocío Gómez-JuanesHealth Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain.ORCID 0000-0002-9040-5508
Jadwiga KoniecznaConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Rafael JiménezStatistical and Psychometric Procedures Applied in Health Sciences (PSICOMEST), Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.ORCID 0000-0002-1181-3221
Maria Jesús Serrano-RipollHealth Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain.ORCID 0000-0002-1869-1132
Maria Antonia Fiol-deRoqueHealth Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain.ORCID 0000-0001-8566-0929
Jerónima MirallesResearch Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB), 07120 Palma de Mallorca, Spain.
Aina M YañezGlobal Health and Lifestyle (EVES Group), Health Research Institute of the Balearic Islands (IdISBa), University Hospital Son Espases (HUSE), 07120 Palma, Spain.ORCID 0000-0001-8527-3937
Dora RomagueraConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.ORCID 0000-0002-5762-8558
Maria Clara Vidal-ThomasResearch Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB), 07120 Palma de Mallorca, Spain.
Joan Llobera-CanavesHealth Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain.
Mauro García-ToroHealth Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain.ORCID 0000-0002-2251-1368
Catalina VicensHealth Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain.
Elena Gervilla-GarcíaStatistical and Psychometric Procedures Applied in Health Sciences (PSICOMEST), Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.ORCID 0000-0003-3194-5499
José Iván OñaDra. Teresa Piqué Primary Health Care Center, Balearic Health Service, 07003 Palma, Spain.
Narges MalihResearch Group on Global Health and Human Development, University of the Balearic Islands (UIB), 07120 Palma, Spain.ORCID 0000-0002-5184-0881
Alfonso LeivaHealth Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain.
Oana BulileteHealth Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain.
Juan José MontañoStatistical and Psychometric Procedures Applied in Health Sciences (PSICOMEST), Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.ORCID 0000-0002-1116-1964
Margalida GiliResearch Institute of Health Sciences (IUNICS), University of Balearic Islands, 07120 Palma de Mallorca, Spain.
Miquel RocaHealth Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain.
Ignacio Ricci-CabelloHealth Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundType 2 diabetes mellitus (T2DM) is a highly prevalent disease associated with an increased risk of comorbidities, premature death, and health costs. Prediabetes is a stage of glucose alteration previous to T2DM, that can be reversed. The aim of the study is to develop and evaluate a low-intensity, multifaceted, digital intervention to prevent T2DM. The intervention comprises: (1) the use of mobile health technology to send tailored text messages promoting lifestyle changes to people at risk of T2DM and (2) the provision of online education to primary healthcare physicians and nurses about management of prediabetes.

methodsIn stages 1-4 we will design, develop and pilot-test the intervention. In Stage 5 we will conduct a phase II, six-month, three-arm, cluster randomized, clinical trial with 42 primary care professionals and 420 patients at risk of T2DM. Patients will be allocated to a control group (usual care), intervention A (patient messaging intervention), or intervention B (patient messaging intervention plus online education to their primary healthcare professionals). The primary outcome will be glycated haemoglobin. All the procedures obtained ethical approval in June 2021 (CEI-IB Ref No: IB4495/21PI). DISCUSSION: Digital health interventions can effectively prevent T2DM and reduce important T2DM risk factors such as overweight or hypertension. In Spain, this type of intervention is understudied. Moreover, there is controversy regarding the type of digital health interventions that are more effective. Findings from this study may contribute to address T2DM prevention, through a low-cost and easily implementable intervention.

Indexed as

Diabetes Mellitus, Type 2Prediabetic StateText MessagingClinical Trials, Phase II as TopicHumansLife StylePrimary Health CareRandomized Controlled Trials as Topicdiet advicedigital health interventionmHealthnursingphysical activityprediabetespreventionSMS interventiontype 2 diabetes mellitus

Identifiers

PMID36429423
PMCPMC9690330

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.